{
  "id": "dedcfcf5edef354e",
  "title": "FDA Approves Rucaparib for the Treatment of Adults With mCRPC",
  "description": "20251218T000000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/fda-approves-rucaparib-for-the-treatment-of-adults-with-mcrpc",
  "published_at": "20251218T000000Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/fda-approves-rucaparib-for-the-treatment-of-adults-with-mcrpc",
    "url_mobile": "",
    "title": "FDA Approves Rucaparib for the Treatment of Adults With mCRPC",
    "seendate": "20251218T000000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/b74e665162b999af748e6a1a830d7a6c1240aac6-3873x3873.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}